A detailed history of Franklin Resources Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Franklin Resources Inc holds 9,764,061 shares of ABT stock, worth $1.12 Billion. This represents 0.33% of its overall portfolio holdings.

Number of Shares
9,764,061
Previous 9,764,061 -0.0%
Holding current value
$1.12 Billion
Previous $1.11 Billion -0.0%
% of portfolio
0.33%
Previous 0.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $118 Million - $139 Million
1,180,040 Added 13.75%
9,764,061 $1.11 Billion
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $1.14 Million - $1.27 Million
11,309 Added 0.13%
8,584,021 $892 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $28 Million - $31 Million
256,012 Added 3.08%
8,572,712 $974 Million
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $11.8 Million - $14.4 Million
130,385 Added 1.59%
8,316,700 $915 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $12.9 Million - $15.5 Million
135,316 Added 1.68%
8,186,315 $793 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $277,548 - $309,246
-2,754 Reduced 0.03%
8,050,999 $878 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $155 Million - $182 Million
-1,600,707 Reduced 16.58%
8,053,753 $816 Million
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $75.9 Million - $89.1 Million
-798,598 Reduced 7.64%
9,654,460 $1.06 Billion
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $11.2 Million - $13 Million
-116,230 Reduced 1.1%
10,453,058 $1.01 Billion
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $12 Million - $14.6 Million
-117,987 Reduced 1.1%
10,569,288 $1.15 Billion
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $72.7 Million - $88.7 Million
638,035 Added 6.35%
10,687,275 $1.26 Billion
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $27.4 Million - $33.5 Million
-236,927 Reduced 2.3%
10,049,240 $1.41 Billion
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $26.2 Million - $29 Million
-224,346 Reduced 2.13%
10,286,167 $1.22 Billion
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $3.28 Million - $3.86 Million
-30,980 Reduced 0.29%
10,510,513 $1.22 Billion
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $16.8 Million - $19.8 Million
-154,170 Reduced 1.44%
10,541,493 $1.26 Billion
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $61.8 Million - $67.3 Million
588,538 Added 5.82%
10,695,663 $1.17 Billion
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $36.8 Million - $44.6 Million
401,144 Added 4.13%
10,107,125 $1.1 Billion
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $28.7 Million - $36.7 Million
374,725 Added 4.02%
9,705,981 $972 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $3.44 Million - $5.04 Million
-54,818 Reduced 0.58%
9,331,256 $736 Million
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $3.61 Million - $4.02 Million
45,961 Added 0.49%
9,386,074 $815 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $2.97 Million - $3.23 Million
36,351 Added 0.39%
9,340,113 $781 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $3.47 Million - $4.05 Million
-47,676 Reduced 0.51%
9,303,762 $782 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $1.47 Million - $1.78 Million
-22,208 Reduced 0.24%
9,351,438 $748 Million
Q4 2018

Feb 12, 2019

BUY
$65.56 - $74.27 $9.73 Million - $11 Million
148,489 Added 1.61%
9,373,646 $678 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $1.65 Million - $1.99 Million
-27,185 Reduced 0.29%
9,225,157 $677 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $12.1 Million - $13.3 Million
209,656 Added 2.32%
9,252,342 $564 Million
Q1 2018

May 10, 2018

BUY
$56.27 - $63.62 $25.1 Million - $28.4 Million
446,071 Added 5.19%
9,042,686 $542 Million
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $594,506 - $636,480
-11,075 Reduced 0.13%
8,596,615 $491 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $414 Million - $462 Million
8,607,690
8,607,690 $459 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.